Cellevate raises 39 million SEK in Seed Financing to accelerate their global commercial launch
LUND, Sweden, October 10, 2023 - Cellevate, an innovative biotech company that develops the next generation of cell culture systems designed to revolutionize biomanufacturing, announced today the successful closure of its recent investment round, securing a total of 39 million SEK. The round was led by Industrifonden, in syndication with the European Innovation Council Fund (EIC Fund) and Onsight Ventures.Cellevate's proprietary nanofiber-based technology - Cellevat3d™ - represents a groundbreaking innovation developed for biomanufacturing of next-generation therapies, including cell and